Loading...
OTCM
BNKL
Market cap1kUSD
May 27, Last price  
0.00USD
Name

Bionik Laboratories Corp

Chart & Performance

D1W1MN
OTCM:BNKL chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
59.29%
Rev. gr., 5y
12.82%
Revenues
2m
+41.73%
7,0007,5005,2006,0000571,945987,4313,246,0382,153,3541,193,4301,273,7121,805,202
Net income
-5m
L-52.48%
-4,661-9,387-13,109-29,5281,036,148-3,936,574-14,728,789-10,556,094-24,934,748-13,620,457-10,407,994-4,946,024
CFO
-3m
L-18.32%
-4,250-8,069-14,609-13,204-4,747,836-6,992,313-7,710,862-9,232,411-9,063,554-4,623,886-4,147,287-3,387,314

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.
IPO date
Jun 12, 2012
Employees
12
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT